| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11934-003-0077-0 |
| P698 | PubMed publication ID | 12756090 |
| P2093 | author name string | Christian Chaussy | |
| Stefan Thüroff | |||
| P2860 | cites work | Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate | Q41077575 |
| Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome | Q50251528 | ||
| Results and side effects of high-intensity focused ultrasound in localized prostate cancer | Q50251642 | ||
| High-intensity focused ultrasound: complications and adverse events. | Q50251865 | ||
| High-intensity focused ultrasound in prostate cancer: results after 3 years. | Q50251872 | ||
| Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer | Q50251928 | ||
| Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results | Q50252543 | ||
| Influence of high-intensity focused ultrasound on the development of metastases. | Q50252965 | ||
| Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience | Q50253182 | ||
| In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. | Q50253794 | ||
| Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog | Q50253883 | ||
| P433 | issue | 3 | |
| P921 | main subject | prostate cancer | Q181257 |
| focused ultrasound | Q50333304 | ||
| P304 | page(s) | 248-252 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Current urology reports | Q26853936 |
| P1476 | title | The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection | |
| P478 | volume | 4 |
| Q89658318 | An Introduction to High Intensity Focused Ultrasound: Systematic Review on Principles, Devices, and Clinical Applications |
| Q30482591 | Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation |
| Q50245848 | Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer |
| Q48029357 | Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer |
| Q37393032 | Comparisons of oncological and functional outcomes among radical retropubic prostatectomy, high dose rate brachytherapy, cryoablation and high-intensity focused ultrasound for localized prostate cancer |
| Q50243127 | Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer |
| Q37141461 | Current status of high-intensity focused ultrasound for prostate cancer: technology, clinical outcomes, and future |
| Q47317738 | Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer |
| Q50248682 | Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer |
| Q33995425 | Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer |
| Q35944856 | Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer |
| Q50250573 | Focused ultrasound surgery. Basics, current status, and new trends |
| Q36761974 | HIFU and cryoablation--non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound? |
| Q50248643 | HIFU in urological oncology |
| Q50239426 | High intensity focused ultrasound (HIFU) : Importance in the treatment of prostate cancer |
| Q28238291 | High intensity focused ultrasound in clinical tumor ablation |
| Q30500940 | High intensity focused ultrasound-induced gene activation in solid tumors |
| Q30501691 | High intensity focused ultrasound-induced gene activation in sublethally injured tumor cells in vitro |
| Q36853061 | High intensity focused ultrasound: physical principles and devices. |
| Q26823776 | High-Intensity Focused Ultrasound (HIFU) in Localized Prostate Cancer Treatment |
| Q26996937 | High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer |
| Q36872271 | High-intensity focused ultrasound (HIFU) for prostate cancer |
| Q36334903 | High-intensity focused ultrasound as a treatment option in renal cell carcinoma |
| Q37778742 | High-intensity focused ultrasound for prostate cancer: a practice guideline |
| Q36184597 | High-intensity focused ultrasound for prostate cancer: long-term followup and complications rate |
| Q38044471 | High-intensity focused ultrasound in prostate cancer: today's outcomes and tomorrow's perspectives. |
| Q37103993 | High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology |
| Q50247277 | High-intensity focused ultrasound in the management of prostate cancer |
| Q43642254 | High-intensity focused ultrasound therapy for clinically localized prostate cancer |
| Q37970412 | High-intensity focused ultrasound therapy for prostate cancer |
| Q50249699 | High-intensity focused ultrasound: a potential salvage treatment for recurrent prostate cancer following radiotherapy |
| Q37691613 | High-intensity focused ultrasound: ready for primetime |
| Q30480603 | High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series |
| Q36064539 | Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up |
| Q50249539 | Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm) as a treatment option |
| Q36801755 | Locally ablative therapies for primary radiation failures: a review and critical assessment of the efficacy. |
| Q27027563 | Low temperature plasma: a novel focal therapy for localized prostate cancer? |
| Q50243464 | MRI-compatible positioning device for guiding a focused ultrasound system for transrectal treatment of prostate cancer. |
| Q33474999 | MRI-guided cryoablation: In vivo assessment of focal canine prostate cryolesions |
| Q36448693 | Management of prostate cancer. Part 2: localized and locally advanced disease |
| Q39103527 | Minimally invasive ablative therapies for definitive treatment of localized prostate cancer in the primary setting |
| Q50248399 | Minimally invasive surgical approaches and management of prostate cancer |
| Q37183470 | Minimally invasive surgical modalities in the management of localized prostate cancer |
| Q35851683 | Minimally invasive treatments in renal cell carcinoma |
| Q50246619 | Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer |
| Q36801746 | Novel techniques for the treatment of localized prostate cancer: evidence of efficacy? |
| Q50248508 | Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer |
| Q97422115 | Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review |
| Q38710610 | Preliminary safety and efficacy results with robotic high-intensity focused ultrasound : A single center Indian experience |
| Q84039281 | Prostate cancer: Defining biochemical failure in patients treated with HIFU |
| Q36246724 | Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer |
| Q50246569 | Rectourethral fistula after high-intensity focused ultrasound therapy for prostate cancer and its surgical management |
| Q30501320 | Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. |
| Q30419463 | Removing atherosclerotic plaque created using high cholesterol diet in rabbit using ultrasound |
| Q37856802 | Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? |
| Q35073996 | SIU/ICUD Consultation on Urethral Strictures: Posterior urethral stenosis after treatment of prostate cancer |
| Q47212709 | Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes |
| Q36728850 | Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer |
| Q97543943 | Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer |
| Q36395155 | Technology insight: High-intensity focused ultrasound for urologic cancers |
| Q41339525 | The Correction of Focal Point Displacement Caused by the Refraction of the Beams in High-Intensity Focused Ultrasound |
| Q36853092 | The clinical applications of high intensity focused ultrasound in the prostate |
| Q35053503 | Three-axis MR-conditional robot for high-intensity focused ultrasound for treating prostate diseases transrectally |
| Q30485862 | Traditional Indian medicine and homeopathy for HIV/AIDS: a review of the literature |
| Q37667867 | Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use. |
| Q50247907 | Transrectal high-intensity focused ultrasound for local treatment of prostate cancer. 2009 Update |
| Q30481118 | Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future |
| Q50246749 | Transurethral resection of the prostate immediately after high‐intensity focused ultrasound treatment for prostate cancer |
| Q47993271 | Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes |
| Q40531588 | Urodynamic evaluation after high-intensity focused ultrasound for patients with prostate cancer |
Search more.